Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea

Recruiting N/A Interventional Study
Cancer (With or Without Metastasis) Interstitial Lung Disease (ILD) Chronic Heart Failure (CHF) COPD Dyspnea
Ready to participate?

Review the details below, then apply to join this clinical trial.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Persistent dyspnea is a debilitating symptom, that is common and difficult to treat. This symptom is found in many different diseases including chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), chronic heart failure (CHF), and metastatic cancer. Dyspnea is associated with many other symptoms, including anxiety, depression, and fatigue and is responsible for a significa…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients aged ≥ 18 years and * Primary diagnosis of metastatic cancer, COPD stage at least B or E, ILD, or CHF and * Dyspnea stage NYHA ≥ II or mMRC ≥ 2 Exclusion Criteria: * Have had hypnosis treatment in the last 12 months * Have an estimated life expectancy of less than 6…
Contacts

Lisa Hentsch, Dr med

+41 22 305 66 12

lisa.hentsch@hug.ch

CONTACT

Federica Bianchi, PhD

lisa.hentsch@hug.ch

CONTACT